Baxter International Inc., commonly referred to as Baxter, is a leading global healthcare company headquartered in the United States. Founded in 1931, Baxter has established a strong presence in various operational regions, including North America, Europe, and Asia. The company operates primarily in the medical devices and pharmaceuticals industry, focusing on critical care, renal care, and surgical products. Baxter is renowned for its innovative core products, such as intravenous (IV) solutions, dialysis equipment, and surgical instruments, which are designed to enhance patient outcomes and streamline healthcare delivery. With a commitment to quality and safety, Baxter has achieved significant milestones, including advancements in renal therapies and the development of cutting-edge infusion systems. As a trusted partner in healthcare, Baxter continues to maintain a strong market position, recognised for its dedication to improving patient care worldwide.
How does Baxter's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Baxter's score of 83 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Baxter reported total carbon emissions of approximately 4,332,000,000 kg CO2e, with Scope 1 emissions at about 324,000,000 kg CO2e, Scope 2 emissions at approximately 177,000,000 kg CO2e, and Scope 3 emissions reaching about 3,831,000,000 kg CO2e. This represents a significant increase from 2023, when total emissions were approximately 4,056,000,000 kg CO2e, with Scope 1 at about 359,000,000 kg CO2e, Scope 2 at approximately 220,000,000 kg CO2e, and Scope 3 at around 3,477,000,000 kg CO2e. Baxter has set ambitious climate commitments, aiming to achieve carbon neutrality for its direct operations by 2040. The company plans to reduce absolute Scope 1 and 2 greenhouse gas emissions by 25% by 2030, using 2020 as the base year. Additionally, Baxter has previously committed to reducing greenhouse gas emissions by 45% indexed to revenue from a 2005 baseline by 2015, a target that was achieved. Baxter's emissions data is sourced from Baxter International Inc., and the company is committed to transparency in its climate initiatives, aligning with science-based targets to mitigate climate change impacts.
Access structured emissions data, company-specific emission factors, and source documents
2002 | 2003 | 2005 | 2006 | 2009 | 2010 | 2011 | 2014 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 781,365,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | - | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Baxter is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.